Tag: Loxo Oncology

December 5, 2019 Off

Lilly adds new leadership to new organization Loxo Oncology

Eli Lilly said Thursday it will work with new leadership and strategic direction in oncology R&D, combining the Lilly Research Laboratories (LRL) oncology organization and Loxo Oncology, which was acquired by Lilly in early 2019.

May 29, 2018 Off

FDA accepts larotrectinib Bayer’s New Drug Application and grants priority review

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has accepted Bayer’s partner’s Loxo Oncology’s New Drug Application (NDA), and granted Priority…